Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gholam P et al. – The authors report on a 39–year–old patient with recalcitrant SSc–related digital ulcers treated successfully with sitaxentan (100 mg q.d.), a selective endothelin type A receptor antagonist. During the 6 months of treatment, the authors noticed a remarkable decrease in pain, a nearly complete healing of the preexistent ulcers and no development of new ulcers. No side effects were noted.

Related Articles

Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Journal of Rheumatology, 10/15/09    Relevance Score: 94%

Aerobic Exercise is Safe and Effective in Systemic Sclerosis
International Journal of Sports Medicine, 10/14/09    Relevance Score: 85%

High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis
Annals of Rheumatic Diseases, 10/23/09    Relevance Score: 84%

Systemic Sclerosis: Environmental Factors
Journal of Rheumatology, 10/06/09    Relevance Score: 84%

Mechanisms of vascular damage in systemic sclerosis
Autoimmunity, 10/02/09    Relevance Score: 84%

Today in Autoimmune/Bullous Dz...keeping you current

Hyper IgE syndrome with umbilical hernia
Indian Journal of Dermatology, 11/25/09

Pemphigus vegetans in a patient with colonic cancer
Indian Journal of Dermatology, Venereology and Leprology , 11/19/09

The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites
Journal of the European Academy of Dermatology and Venereology, 11/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address